Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Some women with PCOS have rare genetic variants linked to the condition.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Women also use 5α-reductase inhibitors, and their effects differ from men.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Vegetable protein lowers cholesterol and protein deficiency can cause health issues.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Diabetes often causes various skin problems and complications.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Skin tags in severely obese people may indicate higher blood pressure and diabetes risk.